PET-MRI Hybrid Enables New Approaches for Neuro-Imaging Scans
By MedImaging International staff writers Posted on 11 Apr 2017 |
Hybrid imaging techniques that combine Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) make use of the detailed images of human anatomy that MRI can provide, together with assessments of tissue function characteristics provided by PET imaging.
The new PET-MRI technique and other advanced neuro-imaging modalities, intended for the early diagnosis of conditions such as dementia and stroke are being displayed at the RadiologyAsia 2017 conference. The conference will host advanced medical imaging experts, and is taking place on May 19-20, 2017. The conference theme is “Bringing state-of-the-art imaging into clinical practice.”
The occurrence of dementia among an aging population is on the rise, and as the disease progresses it can result in ever increasing neuro-degenerative problems for patients. For this reason, early diagnosis is critical for improved patient outcomes.
The new PET-MRI technology provides both volumetric imaging information, as well as metabolic data for the diagnosis of early dementia. PET-MRI and the other new imaging techniques are already enabling clinical researchers to evaluate new drug therapies in clinical trials, and treat dementia and other conditions early, before they result in significant morbidity.
The new PET-MRI technique and other advanced neuro-imaging modalities, intended for the early diagnosis of conditions such as dementia and stroke are being displayed at the RadiologyAsia 2017 conference. The conference will host advanced medical imaging experts, and is taking place on May 19-20, 2017. The conference theme is “Bringing state-of-the-art imaging into clinical practice.”
The occurrence of dementia among an aging population is on the rise, and as the disease progresses it can result in ever increasing neuro-degenerative problems for patients. For this reason, early diagnosis is critical for improved patient outcomes.
The new PET-MRI technology provides both volumetric imaging information, as well as metabolic data for the diagnosis of early dementia. PET-MRI and the other new imaging techniques are already enabling clinical researchers to evaluate new drug therapies in clinical trials, and treat dementia and other conditions early, before they result in significant morbidity.
Latest MRI News
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs
- Abbreviated Breast MRI Effective for High-Risk Screening without Compromising Diagnostic Accuracy